- "Emergent
Biosolutions to
acquire cholera and
typhoid vaccines in $270
million deal". The
Washington Post. Washington, DC. "History".
Emergent BioSolutions. Retrieved...
-
Secretary for
Preparedness and
Response in 2017,
consulted for
Emergent BioSolutions and co-owned a
company linked to its founder,
without disclosing this...
- ACAM2000 is a
smallpox vaccine and an mpox
vaccine manufactured by
Emergent Biosolutions. It
provides protection against smallpox for
people determined to be...
- (formerly MedImmune).
Maryland is home to
defense contractor Emergent BioSolutions,
which manufactures and
provides an
anthrax vaccine to U.S. government...
-
sponsored by
Mothers Against Prescription Drug
Abuse (MAPDA) and
Emergent Biosolutions,
manufacturer of the
overdose antagonist Narcan,
highlights the drug...
- German-American
businessman and philanthropist, and
founder of
Emergent BioSolutions. Fuad El-Hibri was born in Hildesheim, Germany. He
spent his childhood...
- 2021–2022, Novo
Holdings have
announced an
increased investment focusing on
Biosolutions (also
known under the term
bioindustrials or
biotechnologies within the...
-
January 2018.
Retrieved 4 July 2022.
Emergent BioSolutions (3
September 2019). "Emergent
BioSolutions Awarded 10-Year HHS
Contract to
Deliver ACAM2000...
- (A, B, C, D, E, F, G) - (Equine) (trade name BAT), made by
Emergent BioSolutions Canada Inc. (formerly
Cangene Corporation), is a licensed, commercially...
-
Coronavirus Crisis during the May 19, 2021,
hearings involving Emergent BioSolutions founder Faud El-Hibiri and its CEO
Robert G. Kramer. In the aftermath...
